Siena Salvatore
Full professor
SSD
MED/06 - MEDICAL ONCOLOGY
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY
Research fields and competencies
Contacts
Workplace
Additional phone numbers
University email address
E-mail
Teaching - Programme courses
Bachelors and masters
A.Y. 2021/2022
A.Y. 2020/2021
A.Y. 2019/2020
A.Y. 2018/2019
A.Y. 2017/2018
Postgraduate programmes
A.Y. 2020/2021
1st level vocational master
- Metodologia clinica oncologica (Master in management degli studi clinici in oncologia ed emato-oncologia - primo livello)
2nd level vocational master
- Patologia oncologica nel ciclo di vita (Master in Psiconcologia - II Livello)
A.Y. 2019/2020
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Medical oncology (Postgraduate School of Gynecology and Obstetrics)
- Oncologia medica (Postgraduate School of Hematology)
- Oncologia medica (Postgraduate Specialization of Internal Medicine)
- Oncologia medica (Postgraduate School of General Surgery)
- Oncologia medica (Postrgraduate School of Geriatric Medicine)
- Oncologia medica 1 (Postgraduate School of Medical Oncology)
- Oncologia medica 2 (Postgraduate School of Medical Oncology)
- Oncologia medica 3 (Postgraduate School of Medical Oncology)
- Oncologia medica 4 (Postgraduate School of Medical Oncology)
- Oncologia medica 5 (Postgraduate School of Medical Oncology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology Reserved For Non-Doctors)
A.Y. 2018/2019
1st level vocational master
- Metodologia clinica oncologica (Master in management degli studi clinici in oncologia ed emato-oncologia - primo livello)
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
- Medical oncology (Postgraduate School of Gynecology and Obstetrics)
- Neurochirurgia 2 (Postgraduate School of Neurosurgery)
- Oncologia medica (Postgraduate Specialization of Internal Medicine)
- Oncologia medica (Postgraduate School of General Surgery)
- Oncologia medica (Postrgraduate School of Geriatric Medicine)
- Oncologia medica (Postgraduate School of Hematology)
- Oncologia medica 1 (Postgraduate School of Medical Oncology)
- Oncologia medica 2 (Postgraduate School of Medical Oncology)
- Oncologia medica 3 (Postgraduate School of Medical Oncology)
- Oncologia medica 4 (Postgraduate School of Medical Oncology)
- Oncologia medica 5 (Postgraduate School of Medical Oncology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology)
- Oncologia medica tronco comune (Postgraduate School of Clinical Pharmacology and Toxicology Reserved For Non-Doctors)
Research
Publications
Publications
-
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01) : a multicentre, open-label, phase 2 trial / S. Siena, M. Di Bartolomeo, K. Raghav, T. Masuishi, F. Loupakis, H. Kawakami, K. Yamaguchi, T. Nishina, M. Fakih, E. Elez, J. Rodriguez, F. Ciardiello, Y. Komatsu, T. Esaki, K. Chung, Z. Wainberg, A. Sartore-Bianchi, K. Saxena, E. Yamamoto, E. Bako, Y. Okuda, J. Shahidi, A. Grothey, T. Yoshino. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - (2021 May 04). [Epub ahead of print]
-
Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours / L. Paz-Ares, F. Barlesi, S. Siena, M. Ahn, A. Drilon, A. Conley, C. Rolfo, J. Wolf, T. Seto, R. Doebele, A. Kapre, D. Chen, S. McCallum, S. Osborne, G. Demetri. - In: ESMO OPEN. - ISSN 2059-7029. - 6:3(2021 Apr 27).
-
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer / R. Dziadziuszko, M.G. Krebs, F. De Braud, S. Siena, A. Drilon, R.C. Doebele, M.R. Patel, B.C. Cho, S.V. Liu, M. Ahn, C. Chiu, A.F. Farago, C. Lin, C.S. Karapetis, Y. Li, B. Day, D. Chen, T.R. Wilson, F. Barlesi. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 39:11(2021 Apr 10), pp. JCO2003025.1253-JCO2003025.1263.
-
Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond / J. Perez, L. Garrigós, M. Gion, P.A. Jänne, K. Shitara, S. Siena, J. Cortés. - In: EXPERT OPINION ON BIOLOGICAL THERAPY. - ISSN 1471-2598. - (2021 Apr 01). [Epub ahead of print]
-
Personalized therapeutic strategies in HER2-driven gastric cancer / S. Ughetto, C. Migliore, F. Pietrantonio, M. Apicella, A. Petrelli, L. D'Errico, S. Durando, D. Moya-Rull, S.E. Bellomo, S. Rizzolio, T. Capelôa, S. Ribisi, M. Degiuli, R. Reddavid, I. Rapa, U. Fumagalli, S. De Pascale, D. Ribero, C. Baronchelli, G. Sgroi, E. Rausa, G.L. Baiocchi, S. Molfino, S. Manenti, M. Bencivenga, M. Sacco, C. Castelli, S. Siena, A. Sartore-Bianchi, F. Tosi, F. Morano, A. Raimondi, M. Prisciandaro, A. Gloghini, S. Marsoni, A. Sottile, I. Sarotto, A. Sapino, C. Marchiò, P. Cassoni, S. Guarrera, S. Corso, S. Giordano. - In: GASTRIC CANCER. - ISSN 1436-3291. - (2021 Mar 23). [Epub ahead of print]